To validate this hypothesis, we designed a 479-bpbiotin-labeled double-stranded DNA probe corresponding to the 5’-flanking sequence of the COX-2 gene promoter region to pull down nuclear proteins in four colon cancer cell lines, and mass spectrometry was then used to identify the bound proteins. The gene discussed is PTGS2; the disease is malignant colon neoplasm.